Vexol

— THERAPEUTIC CATEGORIES —
  • Ocular allergy/inflammation

Vexol Generic Name & Formulations

General Description

Rimexolone 1%; oph susp; contains benzalkonium chloride.

Pharmacological Class

Steroid.

How Supplied

Susp—5mL, 10mL

Vexol Indications

Indications

Post-op inflammation. Anterior uveitis.

Vexol Dosage and Administration

Adult

Post-op: 1–2 drops into conjunctival sac(s) 4 times daily; start 24 hrs after surgery and continue through 1st 2 weeks post-op. Uveitis: 1–2 drops into the conjunctival sac(s) every hour while awake for 1st week, then 1 drop every 2 hrs while awake for 2nd week, then taper until resolved.

Children

Not recommended.

Vexol Contraindications

Contraindications

Epithelial herpes simplex keratitis and other viral infections including vaccinia, varicella. Ocular mycobacterial, fungal, or untreated purulent infections.

Vexol Boxed Warnings

Not Applicable

Vexol Warnings/Precautions

Warnings/Precautions

Corneal or scleral thinning. Monitor intraocular pressure. Pregnancy (Cat.C). Nursing mothers: not recommended.

Vexol Pharmacokinetics

See Literature

Vexol Interactions

Not Applicable

Vexol Adverse Reactions

Adverse Reactions

Blurred vision, discharge, discomfort, ocular pain, increased intraocular pressure, foreign body sensation, hyperemia, pruritus; may mask secondary ocular infections; ocular hypertension/glaucoma, optic nerve damage, defects in visual acuity and visual fields, posterior subcapsular cataract formation, superinfection possible with prolonged use.

Vexol Clinical Trials

See Literature

Vexol Note

Not Applicable

Vexol Patient Counseling

See Literature